FDA Approved: NOXAFIL — Supplemental Application (Merck Sharp & Dohme LLC)

View source ↗

Summary

The FDA approved Merck's supplemental application for NOXAFIL (posaconazole), updating the product labeling with new indications/usage details.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Candidiasis
• Invasive Aspergillosis
• Mucormycosis
• Oropharyngeal Candidiasis

Drugs mentioned

• NOXAFIL (POSACONAZOLE)

Snippet

SUPPL AP for NOXAFIL (POSACONAZOLE)